One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Introducing Clinical Trial Updates.
Miller, Kathy D. MD 1,2,,; Friedberg, Jonathan W. MD 2,3,4,
doi : 10.1200/JCO.22.00501
Volume 40(15) pgs. 1599-1711 May 20, 2022
We Cannot Change What We Cannot See: A Rationale for Patient-Reported Outcomes in Pediatric Oncology Clinical Research.
Rosenberg, Abby R. MD, MS, MA 1,2,
doi : 10.1200/JCO.22.00196
Late Breast Cancer Survivorship: Side Effects and Care Recommendations.
Jahan, Nusrat MD 1; Cathcart-Rake, Elizabeth J. MD 1; Ruddy, Kathryn J. MD, MPH 1,,
doi : 10.1200/JCO.22.00049
The Time Toxicity of Cancer Treatment.
Gupta, Arjun MD 1; Eisenhauer, Elizabeth A. MD 2; Booth, Christopher M. MD 2,3,
doi : 10.1200/JCO.21.02810
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Armstrong, Andrew J. MD, ScM 1,,; Azad, Arun A. MBBS, PhD 2,3,; Iguchi, Taro MD, PhD 4,; Szmulewitz, Russell Z. MD 5,; Petrylak, Daniel P. MD 6,; Holzbeierlein, Jeffrey MD 7,; Villers, Arnauld MD 8,; Alcaraz, Antonio MD, PhD 9,; Alekseev, Boris MD 10,; Shore, Neal D. MD 11,; Gomez-Veiga, Francisco MD, PhD 12,13,; Rosbrook, Brad MS 14,; Zohren, Fabian MD, PhD 14,; Yamada, Shunsuke MEng 15,; Haas, Gabriel P. MD 15,; Stenzl, Arnulf MD 16,
doi : 10.1200/JCO.22.00193
Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
Freyer, David R. DO, MS 1,; Lin, Li MS 2; Mack, Jennifer W. MD, MPH 3; Maurer, Scott H. MD 4; McFatrich, Molly MPH 5,; Baker, Justin N. MD 6; Jacobs, Shana S. MD 7; Lucas, Nicole BS 8; Withycombe, Janice S. PhD, MN 9; Tomlinson, Deborah MN 10; Villabroza, Katie Rose BS 11; Waldron, Mia K. PhD, MSN 12; Hinds, Pamela S. PhD 12; Reeve, Bryce B. PhD 13,
doi : 10.1200/JCO.21.02669
Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study.
Kwan, Marilyn L. PhD 1,; Cheng, Richard K. MD, MSc 2,3; Iribarren, Carlos MD, MPH, PhD 1,; Neugebauer, Romain PhD 1; Rana, Jamal S. MD, PhD 1,4; Nguyen-Huynh, Mai MD, MAS 1,5; Shi, Zaixing PhD 6,7; Laurent, Cecile A. MS 1; Lee, Valerie S. MHS 1; Roh, Janise M. MSW, MPH 1; Shen, Hanjie MS 7; Rillamas-Sun, Eileen PhD, MPH 7; Santiago-Torres, Margarita PhD 7; Hershman, Dawn L. MD, MS 8,; Kushi, Lawrence H. ScD 1; Greenlee, Heather ND, PhD, MPH 2,3,7
doi : 10.1200/JCO.21.01738
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.
Greenlee, Heather ND, PhD 1,2,3,; Iribarren, Carlos MD, MPH, PhD 4,; Rana, Jamal S. MD, PhD 4,5; Cheng, Richard MD, MSc 2,3; Nguyen-Huynh, Mai MD, MAS 4,6; Rillamas-Sun, Eileen PhD 1; Shi, Zaixing PhD 1,7; Laurent, Cecile A. MS 4; Lee, Valerie S. MHS 4; Roh, Janise M. MSW, MPH 4; Santiago-Torres, Margarita PhD 1; Shen, Hanjie MS 1; Hershman, Dawn L. MD, MS 8,; Kushi, Lawrence H. ScD 4; Neugebauer, Romain PhD 4,; Kwan, Marilyn L. PhD 4
doi : 10.1200/JCO.21.01736
Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis.
Baek, Min-Hyun MD, PhD 1; Park, Eun Young MS 2,3; Ha, Hyeong In MD, PhD 4; Park, Sang-Yoon MD, PhD 5,; Lim, Myong Cheol MD, PhD 5,6,7,,; Fotopoulou, Christina MD, PhD 8,; Bristow, Robert E. MD, PhD 9
doi : 10.1200/JCO.21.02085
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy.
Harrison, Claire N. MD 1,; Garcia, Jacqueline S. MD 2,; Somervaille, Tim C.P. MBBS, PhD 3,4,; Foran, James M. MD 5,; Verstovsek, Srdan MD, PhD 6,; Jamieson, Catriona MD, PhD 7,; Mesa, Ruben MD 8,; Ritchie, Ellen K. MD 9,; Tantravahi, Srinivas K. MBBS 10,; Vachhani, Pankit MD 11,; O'Connell, Casey L. MD 12,; Komrokji, Rami S. MD 13,; Harb, Jason PhD 14,; Hutti, Jessica E. PhD 14,; Holes, Leanne MBA 14,; Masud, Abdullah A. MS, PhD 14,; Nuthalapati, Silpa PhD 14,; Potluri, Jalaja MD 14,; Pemmaraju, Naveen MD 6,,
doi : 10.1200/JCO.21.02188
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
Jin, Jing MD 1,2,; Tang, Yuan MD 1; Hu, Chen PhD 3,; Jiang, Li-Ming MD 4; Jiang, Jun MD 4; Li, Ning MD 1; Liu, Wen-Yang MD 1; Chen, Si-Lin MD 1; Li, Shuai MD 5; Lu, Ning-Ning MD 1; Cai, Yong MD 5; Li, Yong-Heng MD 5; Zhu, Yuan MD 6; Cheng, Guang-Hui MD 7; Zhang, Hong-Yan MD 8; Wang, Xin MD 9; Zhu, Su-Yu MD 10; Wang, Jun MD 11; Li, Gao-Feng MD 12; Yang, Jia-Lin MD 13; Zhang, Kuan MD 14; Chi, Yihebali MD 15; Yang, Lin MD 15; Zhou, Hai-Tao MD 16; Zhou, Ai-Ping MD 15,; Zou, Shuang-Mei MD 17; Fang, Hui MD 1; Wang, Shu-Lian MD 1; Zhang, Hai-Zeng MD 16; Wang, Xi-Shan MD 16; Wei, Li-Chun MD 18; Wang, Wen-Ling MD 19; Liu, Shi-Xin MD 20; Gao, Yuan-Hong MD 21; Li, Ye-Xiong MD 1
doi : 10.1200/JCO.21.01667
Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update.
Korde, Larissa A. MD 1; Somerfield, Mark R. PhD 2; Hershman, Dawn L. MD 3,,; for the Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline Expert Panel
doi : 10.1200/JCO.22.00503
Response-Adapted Postinduction Strategy in Follicular Lymphoma.
Shibusawa, Motoharu MD; Kusumi, Eiji MD; Murakami, Jun MD, PhD; Tanimoto, Tetsuya MD
doi : 10.1200/JCO.21.02818
Reply to M. Shibusawa et al.
Luminari, Stefano MD; Arcaini, Luca MD; Federico, Massimo MD
doi : 10.1200/JCO.22.00177
Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma?.
Gupta, Tejpal MD; Maheshwari, Guncha MD; Kannan, Sadhana MSc; Nair, Sudhir MCh; Agarwal, Jai Prakash MD
doi : 10.1200/JCO.21.02781
Reply to T. Gupta et al.
Oze, Isao MD, PhD; Kohno, Naoyuki MD, PhD; Hasegawa, Yasuhisa MD, PhD
doi : 10.1200/JCO.22.00114
